Abstract
In the present study, we examined the in vivo and in vitro effects of erythromycin (EM) on epithelial mucus production. We produced hypertrophic and metaplastic changes of goblet cells in rat nasal epithelium by the intranasal instillation of endotoxin. The in vivo effects of EM on epithelial mucus production were studied using this animal model. Intraperitoneal injection of EM (100 mg/kg body weight × 8 days), ampicillin (ABPC, 200 mg/kg body weight × 8 days), and cefalotin (CET, 200 mg/kg body weight × 8 days) inhibited epithelial mucus production induced after 7 days of endotoxin instillation. EM had a greater inhibitory effect than ABPC or CET.The in vivo effects of EM on epithelial mucus secretion were studied using cultured human nasal epithelial cells. Mucus secretion was quantitatively measured by the monoclonal antibody HCS18, which specifically reacts with mucin-like materials in human epithelial goblet cells. The spontaneous mucus secretion from cultured epithelial cells did not change after incubation with 10-4 to 10-6 M EM, 10-4 M ABPC, or 10-4 M CET.These results indicate that EM has a greater inhibitory effect on endotoxin-induced epithelial mucus production than ABPC or CET, and that this effect is not caused by the direct action of EM on epithelial secretory cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.